Navidea Biopharmaceuticals, Inc.

OTCPK:NAVB Stock Report

Market Cap: US$100.0k

Navidea Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NAVB?
Owner TypeNumber of SharesOwnership Percentage
Institutions3600.00036%
Individual Insiders35,922,00035.9%
General Public64,072,02564.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 35.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.8%
John Scott
31,765,971US$31.8k0%no data
1.34%
Irwin Bain
1,344,062US$1.3k0%no data
0.97%
Craig Dais
973,633US$973.60%no data
0.94%
Jill Stefanelli
941,667US$941.70%no data
0.87%
Dana Moss
866,667US$866.70%no data
0.03%
Joshua Wilson
30,000US$30.00%no data
0.00035%
Parallel Advisors, LLC
350US$0.30%no data
0.00001%
WR Wealth Planners LLC
10US$0.010%no data